How does Rejuran's PDRN technology promote skin healing? | Velo-city 2007

How does Rejuran's PDRN technology promote skin healing?

Rejuran's PDRN technology promotes skin healing by fundamentally acting as a biological signal to kickstart and accelerate the body's natural repair mechanisms at the cellular level. The core mechanism hinges on the high-purity Polydeoxyribonucleotide (PDRN) it delivers, which is sourced from the sperm DNA of specific salmon species. This PDRN serves as a "building block" and a "master switch," primarily activating the adenosine A2A receptor pathway. When this pathway is stimulated, it triggers a powerful cascade of events: it ramps up the production of growth factors essential for tissue repair, significantly reduces inflammation that can impede healing, and boosts the formation of new blood vessels (angiogenesis) to deliver oxygen and nutrients directly to the damaged site. Essentially, it tells your dormant or sluggish skin cells, "It's time to rebuild," turning a slow, incomplete healing process into an efficient, comprehensive one.

To understand why this is so effective, we need to look at the science of the molecule itself. PDRN is a specific fraction of DNA, composed of a chain of 50 to 2,000 base pairs. Its power lies in its high degree of biological similarity to human DNA. This "bio-similarity" is crucial because it allows the PDRN to be readily recognized and utilized by our cells without triggering an immune response. Think of it as a universal spare part that fits perfectly into the human body's repair machinery. Once introduced into the dermis—the skin's structural layer—through micro-injections, the PDRN molecules get to work. A key action is the "salvage pathway." Our cells can break down the PDRN into its core components, deoxyribonucleotides, which are then used as raw material to synthesize new, healthy DNA for fibroblasts and other cells crucial for healing. This is particularly important in aged or photodamaged skin, where cellular turnover and DNA repair are notoriously slow.

The most significant and well-documented action of PDRN is its activation of the Adenosine A2A Receptor. This isn't a minor side effect; it's the primary engine of the healing process. When PDRN binds to this receptor, it sets off a series of intracellular signals. One of the most critical outcomes is a substantial increase in the expression of Vascular Endothelial Growth Factor (VEGF). VEGF is the body's primary signal for creating new blood vessels. In clinical settings, studies have shown that PDRN treatment can increase VEGF levels by over 70% within the treated tissue within a matter of days. This surge in angiogenesis is a game-changer for healing. It transforms a poorly supplied, stagnant wound environment into a well-irrigated, dynamic one, flooding the area with oxygen, immune cells, and nutrients while efficiently removing waste products. The following table illustrates the key growth factors stimulated by PDRN and their specific roles in the healing cascade.

Growth Factor Primary Function in Healing Impact of PDRN
VEGF (Vascular Endothelial Growth Factor) Stimulates the growth of new blood vessels (Angiogenesis). Up to 70-80% increase in expression, dramatically improving blood supply.
FGF (Fibroblast Growth Factor) Promotes the proliferation and activity of fibroblasts, the cells that produce collagen. Significant boost, leading to a higher number of active collagen-producing cells.
TGF-β (Transforming Growth Factor Beta) Regulates cell growth and differentiation, crucial for tissue remodeling. Modulates its activity to ensure balanced, scar-free tissue regeneration.

Beyond building new infrastructure, PDRN directly tackles the problem of inflammation. Chronic or excessive inflammation is a major roadblock to effective healing, breaking down tissue faster than it can be rebuilt. By activating the A2A receptor, PDRN exerts a potent anti-inflammatory effect. It dials down the production of pro-inflammatory cytokines like TNF-α and IL-6, molecules that are often elevated in chronic wounds and inflammatory skin conditions. Research papers have documented a reduction in these inflammatory markers by 40-60% following PDRN application. This creates a calmer, more conducive environment for regeneration, shifting the tissue's status from "under attack" to "under construction."

The ultimate goal of all this cellular activity is the restoration of the skin's fundamental support structure: the extracellular matrix, which is primarily made of collagen and elastin. As we age or suffer sun damage, our fibroblasts become lazy and produce less of these critical proteins. PDRN gives them a direct wake-up call. The combination of improved cellular energy (from the salvage pathway), a better blood supply, and a less inflammatory environment results in a dramatic uptick in collagen synthesis. Clinical studies using objective measures like histology (skin biopsies) and ultrasound have consistently shown a 25-35% increase in dermal collagen density after a series of PDRN treatments. This isn't just superficial plumping; it's a genuine restoration of skin thickness and mechanical strength. The new collagen forms in a well-organized, mesh-like pattern, closely mimicking the structure of young, healthy skin, which leads to improved elasticity and a visible reduction in fine lines and acne scars.

The practical application of this technology, as seen in products available through clinics like rejuran, involves a series of micro-injections that deliver the PDRN solution directly into the mid-dermis. This ensures the active ingredient is deposited exactly where it's needed most. A standard treatment protocol for skin rejuvenation might involve 3 sessions spaced 4 weeks apart, with maintenance treatments recommended every 6-12 months. The precision of this delivery method is why the results are so structurally significant compared to topical creams, which struggle to penetrate effectively. The before-and-after data is compelling. For example, in studies focusing on acne scar improvement using standardized grading scales like the ECCA scale, patients typically demonstrate a 40-60% improvement in scar appearance and skin texture after a full treatment cycle. The healing process isn't just about looking better; it's about creating skin that is fundamentally healthier, more resilient, and better equipped to handle future environmental stressors.

Back to Archive